Codes / ICD10CM / M02.27

M02.27 Postimmunization arthropathy, ankle and foot

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Postimmunization arthropathy, ankle and foot (ICD Code: M02.27)

Summary

Postimmunization arthropathy, ankle and foot, is a form of reactive arthritis that develops following vaccination. The condition is characterized by joint inflammation and pain, typically occurring weeks to months after immunization. It is considered a post-vaccination complication linked to immune responses triggered by the vaccine, with symptoms localized to the ankle and foot joints.

Causes

Postimmunization arthropathy is caused by the body's immune response to vaccination. The vaccine stimulates an inflammatory reaction that can affect joints, including the ankle and foot, even after the initial immune response to the vaccine has resolved. The exact mechanism involves immune complex formation and systemic inflammation, though the precise pathways are not fully understood.

Risk Factors

  • History of vaccination, particularly with certain vaccines (e.g., live attenuated or adjuvanted vaccines).
  • Pre-existing joint conditions or autoimmune tendencies.
  • Genetic predisposition to inflammatory arthritis.
  • Delayed or inadequate monitoring after vaccination.

Symptoms

  • Joint pain, swelling, and stiffness in the ankle or foot.
  • Reduced range of motion or difficulty bearing weight.
  • Systemic symptoms like fever or malaise in some cases.
  • Symptoms typically develop weeks to months after vaccination.

Diagnosis

Diagnosis involves a clinical evaluation of symptoms, including joint examination and history of recent vaccination. Laboratory tests may rule out other causes of arthritis, such as infection or autoimmune disease. Imaging studies, like X-rays or MRI, can assess joint damage or inflammation. The timing of symptom onset relative to vaccination is critical for diagnosis.

Treatment Options

Treatment focuses on reducing inflammation and managing pain. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to alleviate symptoms. In severe cases, corticosteroids or disease-modifying antirheumatic drugs (DMARDs) may be prescribed. Physical therapy can help maintain joint function and mobility.

Prognosis and Follow-Up

Most cases resolve with appropriate treatment, though symptoms may persist for weeks to months. Regular follow-up is important to monitor joint function and adjust therapy as needed. Long-term outcomes are generally favorable, but some patients may experience recurrent episodes or chronic joint issues.

Complications

Potential complications include chronic joint pain, reduced mobility, or persistent inflammation. Rarely, severe cases may lead to joint damage or disability if left untreated.

Lifestyle & Prevention

Avoiding known triggers, such as certain vaccines, may reduce risk in susceptible individuals. Maintaining a healthy weight and engaging in low-impact exercise can support joint health. Prompt medical attention for post-vaccination symptoms may prevent progression.

When to Seek Professional Help

Seek care if joint pain, swelling, or stiffness develops after vaccination, especially if symptoms worsen or interfere with daily activities. Immediate evaluation is recommended for severe pain, fever, or inability to bear weight.

Tips for Medical Coders

Document the specific site (ankle and foot) and confirm the temporal relationship between vaccination and symptom onset. Ensure clinical notes support the diagnosis and exclude other causes of arthritis. Use M02.27 only when the ankle and foot are the primary affected sites.

Book a walkthrough

M02.27 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.